Short Bowel Syndrome
📧 Sign up to get email alerts when something new happens for Short Bowel Syndrome.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2026-04-15EMA Authorised: Teduglutide Viatris (teduglutide) — Viatris Limited
EMA authorised Teduglutide Viatris for short bowel syndrome.
-
FDA approval · 2025-09-05FDA Approved: GATTEX — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
FDA approved a supplemental application for Gattex (teduglutide) submitted by Takeda Pharmaceuticals America.
-
FDA approval · 2025-08-13FDA Approved: GATTEX — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
The FDA approved a supplemental application for GATTEX (teduglutide) from Takeda Pharmaceuticals America, Inc. The action expands the drug's…
-
EMA approval · 2025-05-23EMA Authorised: Revestive (teduglutide) — Takeda Pharmaceuticals International AG Ireland
The European Medicines Agency authorised Revestive (teduglutide) for malabsorption syndromes. The decision date was 22 May 2025.
-
FDA approval · 2024-09-19FDA Approved: GATTEX — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
The FDA approved a supplemental application for GATTEX (teduglutide) submitted by Takeda Pharmaceuticals America, Inc., updating its labelin…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2024-02-21FDA Approved: GATTEX — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
The FDA approved a supplemental application for GATTEX (teduglutide) to expand its indication for the management of short bowel syndrome. Th…
-
FDA approval · 2023-01-24FDA Approved: GATTEX — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
The FDA approved a supplemental application for Gattex (teduglutide) submitted by Takeda to modify/expand its labeling for the treatment of …
-
FDA approval · 2021-02-11FDA Approved: GATTEX — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
The FDA approved a supplemental application for GATTEX (teduglutide) submitted by Takeda Pharmaceuticals America. This action updates the dr…
-
FDA approval · 2021-01-29FDA Approved: GATTEX — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
The FDA approved a supplemental application for GATTEX (teduglutide) from Takeda Pharmaceuticals America, Inc., authorizing changes to its a…
-
FDA approval · 2020-07-14FDA Approved: GATTEX — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
The FDA approved a supplemental application for GATTEX (teduglutide) from Takeda Pharmaceuticals America, updating the product labeling.
-
FDA approval · 2019-05-16FDA Approved: GATTEX — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
The FDA approved a supplemental application for GATTEX (teduglutide) by Takeda Pharmaceuticals America, expanding its labeling for short bow…
-
FDA approval · 2018-12-18FDA Approved: GATTEX — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
The FDA approved a supplemental application for GATTEX (teduglutide) from Takeda Pharmaceuticals America, Inc.
-
FDA approval · 2017-07-12FDA Approved: PERTZYE — Supplemental Application (Digestive Care, Inc.)
The FDA approved a supplemental application for PERTZYE (pancrelipase) from Digestive Care, Inc.
-
FDA approval · 2017-03-21FDA Approved: GATTEX — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
The FDA approved a supplemental application for GATTEX (teduglutide) submitted by Takeda Pharmaceuticals America, Inc. This action approves …
-
FDA approval · 2016-05-27FDA Approved: GATTEX — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
The FDA approved a supplemental application for GATTEX (teduglutide) from Takeda Pharmaceuticals America, Inc.
-
FDA approval · 2016-03-30FDA Approved: GATTEX — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
FDA approved a supplemental application for GATTEX (teduglutide) by Takeda Pharmaceuticals America, Inc., for the treatment of short bowel s…
-
FDA approval · 2015-10-05FDA Approved: GATTEX — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
FDA approved a supplemental application for GATTEX (teduglutide) submitted by Takeda Pharmaceuticals America, Inc.
-
FDA approval · 2015-05-18FDA Approved: GATTEX — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
The FDA approved a supplemental application for GATTEX (teduglutide) filed by Takeda Pharmaceuticals America, Inc.
-
FDA approval · 2015-01-05FDA Approved: GATTEX — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
The FDA approved a supplemental application for Gattex (teduglutide) submitted by Takeda Pharmaceuticals America, Inc. The action updates th…
-
FDA approval · 2014-06-26FDA Approved: GATTEX — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
The FDA approved a supplemental application for GATTEX (teduglutide) submitted by Takeda Pharmaceuticals America, Inc.
-
FDA approval · 2012-12-21FDA Approved: GATTEX — Original Application (Takeda Pharmaceuticals America, Inc.)
FDA approved GATTEX (teduglutide) from Takeda Pharmaceuticals America as an Original Application for the treatment of short bowel syndrome t…
-
EMA approval · 2012-06-22European Medicines Agency recommends first medical treatment for patients with short bowel syndrome
EMA recommends the first medical treatment option for patients with short bowel syndrome, signaling a potential new therapy option in this c…